Abstract

Cytotoxic lymphocytes expressing perforin and granzymes are important effectors for the clearance of viral infections, for immune surveillance and rejection of tumors. They also participate in allogeneic transplant rejection and graft versus host disease. The emergence and survival of cytotoxic CD8+ T lymphocytes (CTL), an important subpopulation among cytotoxic lymphocytes, is carefully regulated both at the level of their generation and their removal. The process is further controlled by the fact that CTL are generated in draining lymph nodes but must exert their effector function at distant sites in tissues (1). Control of effector function therefore must be carefully integrated with CTL migration and apoptosis. Dramatic expansion of CTL from their precursors can be achieved by secreted heat shock protein gp96-Ig (2) that is recognized by CD91 on dendritic cells, potent antigen presenting cells for T cells. Heat shock protein vaccines cause clonal expansion of cognate TCR transgenic preCTL from a frequency of 20% of the CD8 pool within one week and, upon boosting the response, to >50% of all CD8 cells. This system offers an ideal setting for assessing the homeostatic control of effector CTL pools in vivo and measuring their effector cell activity. Activated CD8+ CTL express numerous receptors and ligands of the TNF-R family. The role of Fas and Fas-L in T cell survival is well documented. Deficiency of either receptor or ligand results in lymphoproliferative disease and autoimmunity, demonstrating a significant function for Fas and Fas-L in terminating clonal expansion and triggering cell removal. CD8+ CTL of the memory phenotype (CD45RO) upon activation transiently expresses very high levels of CD30, another member of the TNF-R family (3), suggesting an important role for this molecule on CTL. While CD30 is not endowed with a death domain, it can nonetheless signal to FADD via its TRAF binding ability. On the other hand CD30 signals are also able to activate NF-kB and JUNK resulting in proliferation. Recent studies suggest that CD30 signals elicited on cytotoxic lymphocytes may integrate effector function (cytotoxicity), lymphocyte migration and susceptibility to apoptosis. Signals emanating from CD30 up regulated CCR7, down regulated the cytotoxic molecules perforin and granzyme B and affected both pro- and anti-apoptotic molecules. One interpretation of these data suggests that CD30-L expressed in tissues may down regulate effector cell cytotoxicity and redirect CTL towards lymph nodes via the CCR7 receptor (4). Recirculation of CTL to lymph nodes allows reactivation or reprogramming of the effector response, including initiation of apoptosis.

Highlights

  • Cytotoxic lymphocytes expressing perforin and granzymes are important effectors for the clearance of viral infections, for immune surveillance and rejection of tumors

  • Dramatic expansion of CD8+ T lymphocytes (CTL) from their precursors can be achieved by secreted heat shock protein gp96-Ig (2) that is recognized by CD91 on dendritic cells, potent antigen presenting cells for T cells

  • Heat shock protein vaccines cause clonal expansion of cognate TCR transgenic preCTL from a frequency of 20% of the CD8 pool within one week and, upon boosting the response, to >50% of all CD8 cells. This system offers an ideal setting for assessing the homeostatic control of effector CTL pools in vivo and measuring their effector cell activity

Read more

Summary

Introduction

Cytotoxic lymphocytes expressing perforin and granzymes are important effectors for the clearance of viral infections, for immune surveillance and rejection of tumors. Dramatic expansion of CTL from their precursors can be achieved by secreted heat shock protein gp96-Ig (2) that is recognized by CD91 on dendritic cells, potent antigen presenting cells for T cells. Heat shock protein vaccines cause clonal expansion of cognate TCR transgenic preCTL from a frequency of 20% of the CD8 pool within one week and, upon boosting the response, to >50% of all CD8 cells.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.